Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
GS-1811 by Gilead Sciences for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
GS-1811 is under clinical development by Gilead Sciences and currently in Phase I for Head And Neck Squamous Cell Carcinoma...
GS-1811 by Gilead Sciences for Non-Small Cell Lung Cancer: Likelihood of Approval
GS-1811 is under clinical development by Gilead Sciences and currently in Phase I for Non-Small Cell Lung Cancer. According to...
GS-1811 by Gilead Sciences for Adenocarcinoma Of The Gastroesophageal Junction: Likelihood of Approval
GS-1811 is under clinical development by Gilead Sciences and currently in Phase I for Adenocarcinoma Of The Gastroesophageal Junction. According...
GS-1811 by Gilead Sciences for Metastatic Colorectal Cancer: Likelihood of Approval
GS-1811 is under clinical development by Gilead Sciences and currently in Phase I for Metastatic Colorectal Cancer. According to GlobalData,...